Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples
- PMID: 35232347
- DOI: 10.2174/1386207325666220301105850
Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples
Abstract
Aim: This study aims to comprehensively analyse the Ribosomal Protein S6 Kinase A4 (RPS6KA4) and determine the prognostic value for hepatocellular carcinoma (HCC).
Background: Liver cancer is a common type of tumor worldwide, and HCC accounts for about 75 to 85% of all primary liver cancer cases. The Ribosomal S6 protein kinases (RSK) family plays an important regulatory role in cell growth, movement, survival, and proliferation.
Methods: We collected the expression and clinicopathological features of RPS6KA4 in The Cancer Genome Atlas (TCGA) cohort and evaluated the prognostic value of RPS6KA4 in HCC. Gene Ontology (GO)/ Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Set Enrichment Analysis (GSEA) were performed to determine the enrichment pathways of RPS6KA4. Correlation between RPS6KA4 expression and immune infiltration was analyzed. Protein-protein interaction (PPI) network analysis was performed to screen hub genes.
Results: RPS6KA4 overexpression is statistically significant in HCC relative to normal tissues (P < 0.001). Increased expression of RPS6KA4 is associated with higher T stage (p=0.021), pathological stage (p=0.006), α-fetoprotein (AFP) value (p=0.026), and vascular invasion (p=0.023) of HCC. Overexpression of RPS6KA4 predicted worse overall survival (OS, P=0.002), disease-specific survival (DSS, P=0.012), and progress-free interval (PFI, P=0.031) for HCC. Univariate/multivariate Cox regression analysis confirmed that RPS6KA4 was an independent risk factor for HCC (P=0.002 in univariate analysis; P=0.014 in multivariate analysis). GO/KEGG analysis and GSEA analysis suggest that RPS6KA4 plays a precancer role in HCC through epigenetics, cell adhesion, tumor-driven GTPase pathways, infection-related carcinogenesis, and adaptive immunity. Immune infiltration analysis confirmed the strong negative relationship between RPS6KA4 and B cells, CD4+ T cells, macrophages, neutrophils, as well as dendritic cells. Protein-protein interactions (PPI) analysis and hub gene identification revealed the cancer-promoting effects of RPS6KA4 related to RSKs, AP-2, clathrin, and MAPK/ ERK pathways.
Conclusion: RPS6KA4 is a potentially valuable molecule for understanding HCC tumorigenesis. Increased RPS6KA4 might be a promising prognostic factor for low HCC survival.
Keywords: Hepatocellular carcinoma (HCC); Ribosomal Protein S6 Kinase A4 (RPS6KA4); The Cancer Genome Atlas (TCGA); biomarkers; prognosis.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.Bioengineered. 2021 Dec;12(1):7941-7949. doi: 10.1080/21655979.2021.1982844. Bioengineered. 2021. PMID: 34612781 Free PMC article.
-
High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.World J Surg Oncol. 2022 Jan 22;20(1):22. doi: 10.1186/s12957-021-02479-w. World J Surg Oncol. 2022. PMID: 35065633 Free PMC article.
-
Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.Bioengineered. 2021 Dec;12(1):2664-2675. doi: 10.1080/21655979.2021.1938470. Bioengineered. 2021. PMID: 34115569 Free PMC article.
-
Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.Genet Test Mol Biomarkers. 2021 Jul;25(7):504-514. doi: 10.1089/gtmb.2020.0093. Genet Test Mol Biomarkers. 2021. PMID: 34280005
-
A pancancer analysis of the oncogenic role of ZNRF2 in human tumours.J Cell Mol Med. 2023 Nov;27(21):3296-3312. doi: 10.1111/jcmm.17900. Epub 2023 Aug 8. J Cell Mol Med. 2023. PMID: 37551845 Free PMC article. Review.
Cited by
-
METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment.Sci Rep. 2023 Jul 3;13(1):10755. doi: 10.1038/s41598-023-37807-5. Sci Rep. 2023. PMID: 37400463 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous